General MedicationsINJECTIONGeneric

CHIROCAINE

LEVOBUPIVACAINE HYDROCHLORIDE

Standard Dose

EQ 2.5MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview CHIROCAINE is listed in Drugs@FDA under application 020997 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient LEVOBUPIVACAINE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - EQ 2.5MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor PURDUE PHARMA LP Submission history Latest submission status date: 2002-08-30 00:00:00.

Structured Monograph

Clinical summary

Approval overview CHIROCAINE is listed in Drugs@FDA under application 020997 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient LEVOBUPIVACAINE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - EQ 2.5MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor PURDUE PHARMA LP Submission history Latest submission status date: 2002-08-30 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.